776 results on '"ACTH-Secreting Pituitary Adenoma"'
Search Results
2. Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
3. Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
4. Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Disease
5. An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
6. Diagnostic Yield of Deep Learning Based Denoising MRI in Cushing's Disease
7. SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome (RESCUE)
8. Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
9. A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
10. Collecting Information About Treatment Results for Patients With Cushing's Syndrome
11. Refractory corticotroph adenomas
12. Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
13. Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
14. Hair Cortisol and Cushing's Disease (HAIRCUSH)
15. Open-label Treatment in Cushing's Syndrome (OPTICS)
16. An Overlooked Manifestation of Hypercortisolism: Cerebral Cortical Atrophy and Challenges in Identifying the Etiology of Hypercortisolism – A Report of 2 Pediatric Cases.
17. Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms (COSHING)
18. Neurochirurgia degli adenomi ipofisari ACTH secernenti
19. Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders (CHROnOS)
20. Thrombosis in Cushing’s disease; raising the flag of concern.
21. Pituitary and Sellar Tumors
22. Postoperative Thrombosis Prevention in Patients With CD
23. Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
24. A human ACTH-secreting corticotroph tumoroid model Novel Human ACTH-Secreting Tumor Cell in vitro Model
25. Treatment of Cushing's Disease With R-roscovitine
26. Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease (LINC-4)
27. Low but not undetectable early postoperative nadir serum cortisol predicts sustained remission in Cushing’s disease
28. Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease
29. Recurrent Cushing Disease: An Extensive Review on Pros and Cons of Different Therapeutic Approaches.
30. Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease
31. Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition (TICSI)
32. Safety and Efficacy of LCI699 in Cushing's Disease Patients
33. Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
34. Impact of [11C]-Methionine PET/MRI in the Detection of Pituitary Adenomas Secreting ACTH and Causing Cushing's Disease (IMPEC)
35. Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
36. Long-term Cardiovascular Risk in Cured Cushing's Patients
37. Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
38. Seoul National University Pituitary Disease Cohort Study (SNU-PIT)
39. Cushing's Disease Complications (COMPLICUSHING)
40. Caracterización de pacientes con tumores hipofisarios atendidos en el Hospital "Hermanos Ameijeiras" entre 2017 y 2019.
41. Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
42. Cushing´s Disease Epidemiology in Sweden
43. Prevention of Metabolic Complications of Glucocorticoid Excess
44. Circadian Plasma Cortisol Measurements Reflect Severity of Hypercortisolemia in Children with Different Etiologies of Endogenous Cushing Syndrome
45. Targeting the ERK pathway for the treatment of Cushing’s disease
46. Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
47. Rhinological Outcomes in Endonasal Pituitary Surgery
48. An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. (SEASCAPE)
49. Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
50. Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.